Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response

Pharmaceutical Research - United States
doi 10.1007/s11095-014-1308-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics Among Medicaid Recipients With Schizophrenia

Journal of Medical Economics
Health Policy
2019English

Both Typical and Atypical Long-Acting Injectable Antipsychotics in Bipolar Disorder: A Retrospective Chart Review

Journal of Mood Disorders
2014English

Atypical Antipsychotics

PharmacoEconomics & Outcomes News
1999English

Pmh23 - Real-World Costs and Budget Impact of Long-Acting Injection Atypical Antipsychotics for the Management of Schizophrenia in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Atypical Antipsychotics

2004English

Atypical Antipsychotics

2004English

Metabolic Effect of Atypical Antipsychotics

Kansas Journal of Medicine
2010English

What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

Atypical Antipsychotics for the Treatment of Disruptive Behavior

Pediatric Annals
Child HealthPediatricsPerinatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy